饮食与慢性肠病患者治疗反应的关联:一项回顾性多中心研究
Sofia D Rodrigues1,2, Beatriz Mendoza1,3, Maria J Dias1,4
1Veterinary Teaching Hospital, Faculty of Veterinary Medicine, University of Lisbon, Lisbon, Portugal.
Journal of veterinary internal medicine
|May 6, 2025
概括
化蛋白饮食有效治疗患有慢性肠病 (CE) 的狗. 对于非响应性肠道病变 (NRE) 的狗,切换到替代饮食也显示出积极的结果.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 狗胃肠病学 狗胃肠病学
- 营养管理 营养管理
背景情况:
- 化蛋白饮食是对以前没有接受过治疗的慢性肠道病变 (CE) 的狗的常见一线治疗.
- 了解饮食干预措施的有效性对于管理狗胃肠道疾病至关重要.
研究的目的:
- 为了评估水解饮食的有效性,在狗与先天的CE.
- 评估对非响应性肠道病变 (NRE) 的狗进行额外的饮食试验的影响.
主要方法:
- 一项回顾性多中心队列研究分析了81只以前没有经过CE的狗和23只经过NRE的狗的医疗记录.
- 狗被过渡到水解 (原始-CE) 或替代 (NRE) 饮食.
- 在4周后,使用便一致性得分或狗炎性肠病活动指数 (CIBDAI) 评估了临床反应.
主要成果:
- 在20%的先验CE病例中,只改变了水解饮食,88%的人表现出改善的便一致性 (p < 0.001).
- 在70%的NRE病例中,只有替代饮食被改变,69%的CIBDAI得分下降 (p < 0.001).
结论:
- 这项研究支持使用水解饮食作为对狗原始CE的主要治疗方法.
- 用替代饮食进行额外的饮食试验似乎有利于在狗患者中管理NRE.
相关概念视频
Chronic Bowel Disorders: Introduction
319
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
319
Drugs for Treatment of Diarrhea-Predominant IBS
117
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
117
Chronic Pancreatitis II: Collaborative Care
49
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
49
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
241
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
241
Inflammatory Bowel Disease IV: Pharmacological Management
80
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
80


